Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children

Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse transcriptase inhibitor, has recently been approved by the U.S. Food and Drug Administration for the treatment of human immunodeficiency virus (HIV) infection. In adults, FTC has demonstrated linear kinetics over a wide dose ran...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Wang, Laurene H., Wiznia, Andrew A., Rathore, Mobeen H., Chittick, Gregory E., Bakshi, Saroj S., Emmanuel, Patricia J., Flynn, Patricia M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2004
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC310155/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14693538/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.1.183-191.2004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi